Cargando…
18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy
BACKGROUND: Prostate cancer is highly prevalent worldwide. Androgen deprivation therapy (ADT) remains the treatment of choice for incurable prostate cancer, but majority of patients develop disease recurrence following ADT. There is therefore an urgent need for early detection of treatment resistanc...
Autores principales: | Malviya, Gaurav, Patel, Rachana, Salji, Mark, Martinez, Rafael S., Repiscak, Peter, Mui, Ernest, Champion, Susan, Mrowinska, Agata, Johnson, Emma, AlRasheedi, Maha, Pimlott, Sally, Lewis, David, Leung, Hing Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688773/ https://www.ncbi.nlm.nih.gov/pubmed/33237350 http://dx.doi.org/10.1186/s13550-020-00728-9 |
Ejemplares similares
-
Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
por: Bach-Gansmo, Tore, et al.
Publicado: (2022) -
A Comparative Evaluation of Mediastinal Nodal SUVmax and Derived Ratios from (18)F-FDG PET/CT Imaging to Predict Nodal Metastases in Non-Small Cell Lung Cancer
por: AlRasheedi, Maha, et al.
Publicado: (2023) -
In Molecular Pursuit of Bone Metastasis by Fluciclovine PET
por: Lindenberg, Liza
Publicado: (2017) -
F-18 Fluciclovine PET-CT Findings and Pseudoprogression on Immunotherapy
por: Poindexter, Bradley C, et al.
Publicado: (2022) -
Detection of Recurrent Prostate Cancer With (18)F-Fluciclovine PET/MRI
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2020)